VEGFR2/CD309 anticorps (pTyr951)
Aperçu rapide pour VEGFR2/CD309 anticorps (pTyr951) (ABIN362037)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr951
-
Specificité
- The antibody detects endogenous level of VEGFR2 only when phosphorylated at tyrosine 951.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
Immunogène
- Peptide sequence around phosphorylation site of pTyr951 (K-D-Y (p) -V-G) derived from Human VEGFR2. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
-
Isotype
- IgG
-
-
anti-VEGF Receptor 2 (VEGFR2) (AA 20-244) antibody
VEGFR2 Reactivité: Souris, Rat WB, IHC, FACS, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibodyVEGFR2 Reactivité: Humain WB, IHC, FACS, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibodyVEGFR2 Reactivité: Humain WB, FACS, IF, IHC (p) Hôte: Lapin Polyclonal RB01536 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibodyVEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibodyVEGFR2 Reactivité: Humain WB, IHC, ELISA, FACS, IF Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 101-200) antibodyVEGFR2 Reactivité: Humain, Souris, Rat, Lapin ELISA, FACS, IHC (p), IF (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr1214) antibodyVEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibodyVEGFR2 Reactivité: Humain ELISA, FACS Hôte: Souris Monoclonal 1A9A3 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibodyVEGFR2 Reactivité: Humain ELISA, FACS, ICC Hôte: Souris Monoclonal 4B4 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 454-469), (Middle Region) antibodyVEGFR2 Reactivité: Humain WB, IHC, ICC Hôte: Lapin Polyclonal unconjugated
-
-
Indications d'application
-
Western blotting: 1:500-1:1000
Immunohistochemistry: 1:50-1:100
Immunofluorescence: 1:100-1:200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- VEGFR2
-
Sujet
- Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions
-
Poids moléculaire
- 230 kDa
-
NCBI Accession
- NP_002244
-
UniProt
- P35968
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-
